-
·
Your MPN, Your Journey: How New Discoveries Will Impact Personalized Care
Your MPN, Your Journey: How New Discoveries Will Impact Personalized Care Dr. John Mascarenhas of The Tisch Cancer Institute at Mount Sinai and patient advocate Andrew Schorr share the latest breakthroughs in MPN care.
-
·
Clinical Trials Update: What to Know in Myelofibrosis Care
Clinical Trials Update: What to Know in Myelofibrosis Care Following the American Society of Hematology Annual Meeting (ASH), Dr. Naveen Pemmaraju of MD Anderson and patient advocate Ruth Fein Revell discuss the latest myelofibrosis treatment options.
-
·
The Latest in Myelofibrosis: Understanding Promising Treatment Options
The Latest in Myelofibrosis Treatments: Understanding Promising Treatment Options Myelofibrosis experts Raajit Rampal, MD, PhD, from Memorial Sloan Kettering, Gabriela Hobbs, MD, from Dana-Farber/Harvard Cancer Center, and myelofibrosis patient advocate Ruth Fein discuss updates from ASH 2023.
-
·
Myelofibrosis Clinical Trials and Latest Treatments
Clinical Trials and You: How to Navigate Treatment? Patient advocate Ruth Fein Revell, experts Dr. Angela Fleischman and Dr. Ruben Mesa, together with clinical trial nurse Melissa Melendez delve into the cutting-edge realm of myelofibrosis clinical trials.
-
·
The Latest in Myelofibrosis Treatments
The Latest in Myelofibrosis Treatments: What Clinical Trials are Available to Me? Myelofibrosis experts John Mascarenhas, MD, from Mount Sinai and Tania Jain, MBBS, from Johns Hopkins explain cutting-edge therapies. Clinical trial nurse Ashley Giacobbi and myelofibrosis patient advocate Mary Linde share powerful insights to help you navigate all aspects of clinical trials.
